Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy (IARBASP)

Poitiers University Hospital

Status: Invitation-only

Conditions: Respiratory Allergy; Severe Asthma; Biotherapy

Treatments: Other: search for respiratory allergies

Study type: Observational

Funder types: Other

Identifiers

NCT06916104

IARBASP

Details and patient eligibility

About

The aim of this study is to take stock of the situation of adult patients with severe asthma on biotherapy, followed up at Poitiers University Hospital, and in particular to increase our knowledge of factors predictive of response to biotherapy. The main aim is to improve the management of adult severe asthma patients treated with biotherapy, according to their allergic status.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Severe asthma patient on biotherapy
• Age > or = 18 years
• Follow-up at Poitiers University Hospital

Exclusion criteria

• Absence of allergological assessment
• Patient's refusal to participate in study

Trial design

100 participants in 1 patient group

adult patients with severe asthma on biotherapy

Treatment:

Other: search for respiratory allergies